banner

Latest News

Implantable 3D-printed organs could be coming sooner than you think

A recent article from Tech Crunch on Prellis Biologics: At MBC Biolabs, an incubator for biotech startups in San Francisco’s Dogpatch neighborhood, a team of scientists and interns working for the small startup Prellis Biologics have just taken a big step on the path toward developing viable 3D-printed organs for humans. The company, which was founded in 2016 by res...

Read More

New tech allows much faster 3D-printing of human tissue with capillaries

A New Atlas article about Prellis Biologics: Prellis Biologics has brought the science fiction dream of printing human organs for transplant a step forward by developing a fast, high-resolution 3D printing technique that can produce living tissue that includes viable blood-carrying capillaries. The new technique allows the cells to receive enough oxygen and nutrients to survive...

Read More

Rocket Pharmaceuticals to Join Russell 3000® and 2000® Indexes

Press release on Rocket Pharma: Rocket Pharmaceuticals to Join Russell 3000® and 2000® Indexes NEW YORK--(BUSINESS WIRE)--Jun. 22, 2018-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, announced that the Company will join the broad-market Russell 3000® and Russell 2000®Indexes. The ne...

Read More

Presentation of Research Collaboration by Frampton Lab - "Bioprinting of Three-Dimensional Mult

A recent article from Aspect Biosystems: Presentation of Research Collaboration by Frampton Lab - "Bioprinting of Three-Dimensional Multicellular Skin Constructs" Our collaborators from the Frampton Lab at Dalhousie University are presenting research they performed in collaboration with Aspect at the upcoming Skin Research Group of Сanada 5th Annual Symposium. This year, the...

Read More

AARP, startups partner to study digital healthcare technology

A recent article about Omada Health: Clinicians and groups like AARP view in-home digital technology as the future of healthcare and are studying different technologies to assist patients in the home. Research from AARP has found 90% of adults aged 50 and older use technology to stay connected. Based on that research,...Read the full article...

Read More

Lemonaid Health Raises $11M Series A

A recent article on Lemonaid Health fundraising: Lemonaid Health, a San Francisco, CA-based telehealth startup, has raised $11 million in Series A funding led by Novartis Venture Fund and Hikma Ventures and joined by Correlation Ventures, Adaptive Healthcare Fund, Vega Ventures and 415 Ventures. Founded in 2013 by Co-Founders Ian Van Every and Paul Johnson, Lemonaid Health offers online prescr...

Read More

Curai picks up $10.7M to create a smarter system to help patients supply the best info for their doc

From Tech Crunch: Curai picks up $10.7M to create a smarter system to help patients supply the best info for their doctors  There’s been an explosion of medical startups centering their tools around machine learning to help doctors with predictive tools — and now Netflix’s former chief product officer Neil Hunt wants to enter the fray with one that hopes to get the right information f...

Read More

Omada Health Achieves Full CDC Recognition

From PR Newswire: Omada Health Achieves Full CDC RecognitionOmada Health today announced that the company has graduated to full recognition status from the Centers for Disease Control and Prevention (CDC). Omada now becomes the largest Diabetes Prevention Program (DPP) provider, in-person or virtual, to achieve full recognition from the CDC."Today's accomplishment is the culmination of wo...

Read More

Rocket Pharma's lead candidate shows positive effect in Fanconi anemia

From Seeking Alpha: Rocket Pharma's lead candidate shows positive effect in Fanconi anemia Results from a Phase 1/2 clinical trial evaluating Rocket Pharmaceuticals' (NASDAQ:RCKT) lead gene therapy candidate, RP-L102, in patients with Fanconi anemia (FA) showed a treatment effect. The data were presented at ASGCT in Chicago. Five patie...

Read More

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

From News Medical: Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research Rocket Pharmaceuticals, Inc. ("Rocket"), a leading U.S.-based multi-platform gene therapy company, and the Stanford University School of Medicine today announced a strategic collaboration to support the advancement of Fanconi Anemia (FA) and Pyruvate Kinase Deficiency (PKD) gene the...

Read More